Search Results

Giving Tuesday

Giving Tuesday Social Toolkit

FDA Approves the First Interferon for Adults With Polycythemia Vera

This is the first medication approved for PV that patients can take regardless of their treatment history, meaning it can be used to treat this rare f…

LLS Applauds House Passage of Critical Health Reforms

The Leukemia & Lymphoma Society applauds passage of critical reforms by the U.S. House of Representatives. The provisions, components of the Build Ba…

News Release

Angela

I am a Hodgkin lymphoma (HL) cancer survivor. I was first diagnosed with stage HL in . I underwent chemo and radiation. The doctors at my were no l…

Halley

My story with cancer began long before I was diagnosed this year at . When I was years old, my - sister, Hannah, became too tired to play with me. As…

Dan

My name is Dan. I was first diagnosed with multiple myeloma (MM). After a battery of excruciating, painful biopsies and bloodwork, my doctors prescrib…

Amina

I’m years old, and I have stage 3B Hodgkin lymphoma (HL).I was years old, living in New York, and in my final semester of conservatory dance trainin…

New Eyes

To provide eyeglasses to individuals in need Provides a basic pair of single or lined bifocal eyeglasses at no cost to individuals who meet the…

Non-Hodgkin Lymphoma: Know Your Subtype

Topics CoveredWe invite you to learn more about:The importance of knowing your lymphoma (NHL) subtypeHow your NHL subtype guides your treatment goals…

Education Resources

Hair We Share

To help maintain dignity, confidence and to those affected by medical hair loss. Provides a wig free of charge to children years old and under…

FDA Approves New Treatment Option for Patients with Multiple Myeloma at First or Subsequent Relapse

The U.S. Food and Drug Administration (FDA) recently granted the seventh approval to daratumumab for the treatment of multiple myeloma. This injectabl…

News Release

Gary

In I had a lump on my neck, and after strong urging from my wife and my mother, I finally went to my family doctor. My white blood cell counts were r…

Elephants and Tea

To help adolescent and young adult (AYA) patients, survivors, and caregivers know they are not alone in their fight with cancer Provides a free …

TAP Partner News During ASH: Dec 2021

Current and former TAP partners presented new data during the American Society of Hematology (ASH) meeting that took place from December -14th.

WWE and LLS Join Forces

Yescarta® Is First CAR T-cell Therapy to Report Five-Year Survival Data From Pivotal Study Showing Durable Long-Term Survival in Patients With Refractory Large B-cell Lymphoma

December - SANTA MONICA, Calif. - Kite, a Gilead Company (Nasdaq: GILD), today announced data from the pivotal trial of Yescarta® (axicabtagene c…

Secura Bio Announces the Presentation of New COPIKTRA® (duvelisib) Data for the Treatment of Patients with Relapsed or Refractory PTCL

SUMMERLIN, Nev., Dec. , - Secura Bio, Inc., an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impa…